VCS Pharmaceuticals Private Limited
About VCS Pharmaceuticals Private Limited
Data last updated:
VCS Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 06 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2016PTC075520. Its GSTIN is 09AAFCV3354C1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandan Mishra and Shrivandit Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 185 B/248 A/1 Attarsuiya, Allahabad, Uttar Pradesh, India – 211003.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.05 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.69 Lakh (net margin 1.6%) and EBITDA of ₹2.04 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address185 B/248 A/1 Attarsuiya, Allahabad, Uttar Pradesh, India – 211003
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of VCS Pharmaceuticals Private Limited
The main business activity of VCS Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of VCS Pharmaceuticals Private Limited FY 2025 filings available
VCS Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of VCS Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 16% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of VCS Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.04 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.69 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of VCS Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of VCS Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Faith-Build Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Aurangabad, Maharashtra, India |
| Parkem Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Ranchi, Jharkhand, India |
| Zymeds Pharmaceuticals Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Mumbai, Maharashtra, India |
| Lilyan Pharmaceuticals Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 1230.0% | •••• | Ulhasnagar, Maharashtra, India |
| Desano Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 282.0% | •••• | Bengaluru, Karnataka, India |
| VCS Pharmaceuticals Private Limited this company | ₹1.05 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Allahabad, Uttar Pradesh, India |
| Remedies Pharmaceuticals India Private Limited. | ₹1.05 Cr (FY 2020) | •••• | •••• | -24.0% | •••• | New Delhi, Delhi, India |
| Zafodo Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Palakkad, Kerala, India |
| Metina Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Navi Mumbai, Maharashtra, India |
| Kenbrio Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Chandigarh, India |
| Solvmed Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Darbhanga, Bihar, India |
Peers are the five companies nearest above and the five nearest below VCS Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals Private Limited is audited by GAURAV USHA & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GAURAV USHA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandan Mishra | Director | 06 Jan 2016 | 10 Years 9 Months | Current |
| Shrivandit Mishra Also directs: Medberry Food Works LLP | Director | 06 Jan 2016 | 10 Years 9 Months | Current |
Ownership and Shareholding of VCS Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at VCS Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to VCS Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Chandan Mishra was appointed as Director on 06 Jan 2016.
Credit Ratings, Litigation & Regulatory Alerts for VCS Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by VCS Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of VCS Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCV3354C1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of VCS Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VCS Pharmaceuticals Private Limited
VCS Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 06 January 2016 (10+ years old) and is registered under CIN U85191UP2016PTC075520.
VCS Pharmaceuticals reported revenue of ₹1.05 Cr for FY 2024 (up 16% YoY).
VCS Pharmaceuticals has 2 current directors:
- Chandan Mishra - Director
- Shrivandit Mishra - Director
VCS Pharmaceuticals reported a net profit of ₹1.69 Lakh (net margin 1.6%) and EBITDA of ₹2.04 Lakh (EBITDA margin 1.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of VCS Pharmaceuticals is 66% over three years and 32% over five years. In the latest year (FY 2024) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of VCS Pharmaceuticals is 09AAFCV3354C1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of VCS Pharmaceuticals is U85191UP2016PTC075520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VCS Pharmaceuticals was incorporated on 06 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of VCS Pharmaceuticals by revenue are Faith-Build Pharmaceuticals Private Limited, Parkem Pharmaceuticals Private Limited, Zymeds Pharmaceuticals Private Limited, Lilyan Pharmaceuticals Private Limited, Desano Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Chandan Mishra was appointed as Director on 06 Jan 2016. Shrivandit Mishra was appointed as Director on 06 Jan 2016.
The registered office of VCS Pharmaceuticals is at 185 B248 A1 Attarsuiya, Allahabad, Uttar Pradesh, India – 211003.